Spending Estimates for Gastric Cancer in Central Brazil
DOI:
https://doi.org/10.1590/s2175-97902022e181069Keywords:
Gastric neoplasms, Treatment, Spending, Cost, Cost analysisAbstract
Stomach cancer is the second leading cause of death by cancer worldwide and is even more pronounced in South America. In Brazil, it is estimated that an increase in the number of cases due to this cancer occurred in the biennium 2018-2019. In this study, we investigated the expenditures of the State Health Department of Goiás on hospitalizations and treatment of gastric cancer for the Unified Health System (SUS) from 2008-2016. This is a cross-sectional, descriptive, and analytical study based on secondary data from the Unified Health System computing department (DATASUS) and the System of Management of the Table of Procedures, Medications, Orthosis, Prosthesis, and Special Materials of SUS through CONECTA-SUS related to International Classification of Diseases-10/C16 (ICD-10/C16) procedures for gastric neoplasms. A total of I$ 5,697,958.20 was spent on gastric tumor in the last nine years in Goiás, I$ 4,492,916.67 (0.3%) on hospitalizations, and I$ 1,997,120.91 on treatment. This study presents a current and relevant estimate of the costs of gastric cancer patients in Goiás. Moreover, we provide information on the extent of the cancer issue to public health. Our analysis offers components for service management and studies that reduce resource allocation in more rational ways.
Downloads
References
American Cancer Society. Cancer Facts & Figures 2015. Atlanta, Georgia; 2015. 52 p. Disponível em: https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2015.html
Bittencourt SA, Camacho LAB, Leal M do C. O Sistema de Informação Hospitalar e sua aplicação na saúde coletiva. Cad Saúde Pública. 2006;22(1):19-30. doi:10.1590/S0102- 311X2006000100003.
» https://doi.org/10.1590/S0102- 311X2006000100003
Brasil. Ministério da Saúde. Fundação Oswaldo Cruz. A experiência brasileira em sistemas de informação em saúde. vol. I. Brasília (DF): Ministério da Saúde; 2009a. 148 p. Disponível em: http://bvsms.saude.gov.br/bvs/publicacoes/experiencia_brasileira_sistemas_saude_volume1.pdf
» http://bvsms.saude.gov.br/bvs/publicacoes/experiencia_brasileira_sistemas_saude_volume1.pdf
Brasil. Ministério da Saúde. Fundação Oswaldo Cruz. A experiência brasileira em sistemas de informação em saúde. vol. II. Brasília (DF): Ministério da Saúde ; 2009b. 148 p. Disponível em: https://www.paho.org/bra/index.php?option=com_docman&view=download&alias=299- a-experiencia-brasileira-em-sistemas-informacao-em- saude-v-2-9&category_slug=informacao-e-analise-saude- 096&Itemid=965
» https://www.paho.org/bra/index.php?option=com_docman&view=download&alias=299- a-experiencia-brasileira-em-sistemas-informacao-em- saude-v-2-9&category_slug=informacao-e-analise-saude- 096&Itemid=965
Brasil. Ministério da Saúde. Sistema nacional de vigilância em saúde : relatório de situação. Goiás: Brasília (DF): Ministério da Saúde ; 2011. 39 p. Disponível em: < http://bvsms.saude.gov.br/bvs/publicacoes/sistema_nacional_vigilancia_saude_go_5ed.pdf>.
» http://bvsms.saude.gov.br/bvs/publicacoes/sistema_nacional_vigilancia_saude_go_5ed.pdf
Brasil. Ministério da Saúde. Secretaria de Ciência, Tecnologia e Insumos Estratégicos. Comissão Nacional de Incorporação de Tecnologias no SUS. Diretrizes Diagnósticas e Terapêuticas: Adenocarcinoma de Estômago. Brasília (DF): Ministério da Saúde ; 2017. 20 p.
Cavaleiro PM, Peleteiro B, Lunet N, Barros H. Helicobacter pylori infection and gastric cardia cancer: Systematic review and meta-analysis. Cancer Causes Control. 2011;22:375-387. doi:10.1007/s10552-010-9707-2.
» https://doi.org/10.1007/s10552-010-9707-2
Chen C, Chen Q, Zhao Q, Liu M, Guo J. Value of Combined Detection of Serum CEA, CA72-4, CA19-9 and ca12- 5 in the Diagnosis of Gastric Cancer. Ann Clin Lab Sci. 2017;47(3):260-263.
Drummond MF, Sculpher MJ, Torrance GW, O’Brien BJ, Stoddart GL. Methods for the Economic Evaluation of Health Care Programmes. 3 edition. Oxford; NewYork: Oxford University Press; 2005. 396p.
El-Serag HB, Mason AC, Petersen N, Key CR. Epidemiological differences between adenocarcinoma of the oesophagus and adenocarcinoma of the gastric cardia in the USA. Gut. 2002;50(3):368-372. doi:10.1136/gut.50.3.368.
» https://doi.org/10.1136/gut.50.3.368
Featherstone H, Whitham L. The cost of cancer. Reino Unido: Policy Exchange; 2010. 20p. Disponível em: https://policyexchange.org.uk/wp-content/uploads/2016/09/the- cost-of-cancer-feb-10.pdf
» https://policyexchange.org.uk/wp-content/uploads/2016/09/the- cost-of-cancer-feb-10.pdf
Flannery K, Cao X, He J, Zhong Y, Shah AY, Kamat AM. Survival rates and health care costs for patients with advanced bladder cancer treated and untreated with chemotherapy. Clin Genitourin Cancer. 2018;16(4):e909-e917. doi:10.1016/j. clgc.2018.03.002.
» https://doi.org/10.1016/j. clgc.2018.03.002
Giusti ACB de S, Oliveira SPTC de, Santos J dos, Meira KC, Camacho AR, Guimarães RM, et al. Trends and predictions for gastric cancer mortality in Brazil. World J Gastroenterol. 2016;22(28):6527-6538. doi:10.3748/wjg.v22.i28.6527.
» https://doi.org/10.3748/wjg.v22.i28.6527
Instituto Nacional de Câncer José Alencar Gomes da Silva. INCA. Coordenação de Prevenção e Vigilância. Estimativa 2018: Incidência de Câncer no Brasil. Rio de Janeiro: INCA; 2017. 128 p.
Instituto Nacional de Câncer José Alencar Gomes da Silva. INCA. Coordenação de Prevenção e Vigilância. INCA. Estimativa 2016: Incidência de Câncer no Brasil. Rio de Janeiro: INCA ; 2015. 122 p. Disponível em: https://www.inca.gov.br/bvscontrolecancer/publicacoes/edicao/Estimativa_2016.pdf
» https://www.inca.gov.br/bvscontrolecancer/publicacoes/edicao/Estimativa_2016.pdf
Karimi P, Islami F, Anandasabapathy S, Freedman ND, Kamangar F. Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev. 2014;23(5):700-713. doi:10.1158/1055-9965. EPI-13-1057.Gastric.
» https://doi.org/10.1158/1055-9965
Kust, RE. Estimativa dos custos diretos da assistência oncológica do câncer de pulmão não pequenas células avançado em um hospital público de referência. [dissertação de mestrado]. Rio de Janeiro: Fundação Oswaldo Cruz (FIOCRUZ), Escola Nacional de Saúde Pública; 2015. Disponível em: https://www.arca.fiocruz.br/handle/icict/37389
» https://www.arca.fiocruz.br/handle/icict/37389
Marqués LJM, González PM, Cruz CM. Current perspectives on gastric cancer. Gastroenterol Clin North Am. 2016;45(3):413-428. doi:10.1016/j.gtc.2016.04.002.
» https://doi.org/10.1016/j.gtc.2016.04.002
Pan American Health Organization. PAHO. Folha informativa - Câncer. Brasília (DF): OPAS, 2018. [citado em 12 de dezembro de 2018] Disponível em: Disponível em: https://www.paho.org/bra/index.php?option=com_content&view=article&id= 5588:folha-informativa-cancer&Itemid=1094
» https://www.paho.org/bra/index.php?option=com_content&view=article&id= 5588:folha-informativa-cancer&Itemid=1094
Reitsma MB, Fullman N, Ng M, Salama JS, Abajobir A, Abate HK et al. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the Global Burden of Disease Study 2015. Lancet. 2017;389:1885-906. doi:10.1016/S0140- 6736(17)30819-X.
» https://doi.org/10.1016/S0140- 6736(17)30819-X
Reis SC dos, Noronha K, Wajnman S. Envelhecimento populacional e gastos com internação do SUS : uma análise realizada para o Brasil entre 2000 e 2010. R Bras Est. Pop. 2016;33(3):591-612.
World Bank. PPP conversion factor, GDP (LCU per international $). Available in: < Available in: https://data.worldbank.org/ indicator/PA.NUS.PPP >. Acess in: 09 Mar 2020.
» https://data.worldbank.org/ indicator/PA.NUS.PPP
World Health Organization. WHO. International Agency for Research on Cancer. IARC. Helicobacter pylori Working Group Reports. Helicobacter pylori eradication as a strategy for preventing gastric cancer. Lyon, France: WHO Press. 2014a. 181 p. Disponível em: https://publications.iarc.fr/ Book-And-Report-Series/Iarc-Working-Group-Reports/-Em-Helicobacter-Pylori-Em-Eradication-As-A-Strategy- For-Preventing-Gastric-Cancer-2014
» https://publications.iarc.fr/ Book-And-Report-Series/Iarc-Working-Group-Reports/-Em-Helicobacter-Pylori-Em-Eradication-As-A-Strategy- For-Preventing-Gastric-Cancer-2014
World Health Organization. WHO. CID-10 VOL. 1: Classificação Estatística Internacional de Doenças. Lyon, France: WHO Press . 2014b. 1200 p.
World Health Organization. WHO. International Agency for Research on Cancer. IARC. Edited by: Stewart Bernard W, Wild Christopher P. World Cancer Report 2014. Lyon, France: WHO Press ; 2014c. 632 p.
Yamaoka Y. Mechanisms of disease: Helicobacter pylori virulence factors. Nat Rev Gastroenterol Hepatol. 2010;7:629- 641. doi:10.1038/nrgastro.2010.154.
» https://doi.org/10.1038/nrgastro.2010.154
Zhang RG, Duan GC, Fan QT, Chen SY. Role of Helicobacter pylori infection in pathogenesis of gastric carcinoma. World J Gastrointest Pathophysiol. 2016;7(1):97-107. doi:10.4291/wjgp.v7.i1.97.
» https://doi.org/10.4291/wjgp.v7.i1.97
Zilberstein B, Malheiros C, Lourenço LG, Kassab P, Jacob CE, Weston AC et al. Consenso brasileiro sobre câncer gástrico: diretrizes para o câncer gástrico no Brasil. ABCD Arq Bras Cir Dig. 2013;26(1):2-6. doi:10.1590/S0102-67202013000100002.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content of the journal, except where identified, is licensed under a Creative Commons attribution-type BY.
The on line journal has open and free access.
